REFERENCES
- Black RE, Morris SS, Bryce J. Where and why are 10 million children
dying every year? Lancet . 2003;361:2226-2234.
- Duke T. Neonatal pneumonia in developing countries. Arch Dis
Child Fetal Neonatal Ed . 2005;90:F211-F219.
- Mortality GBD and Causes of Death C. Global, regional, and national
life expectancy, all-cause mortality, and cause-specific mortality for
249 causes of death, 1980-2015: a systematic analysis for the Global
Burden of Disease Study 2015. Lancet . 2016;388:1459-1544.
- Chakraborty M, McGreal EP, Kotecha S. Acute lung injury in preterm
newborn infants: mechanisms and management. Paediatr Respir
Rev . 2010;11:162-170.
- Heidemann SM, Nair A, Bulut Y, Sapru A. Pathophysiology and Management
of Acute Respiratory Distress Syndrome in Children. Pediatr Clin
North Am . 2017;64:1017-1037.
- Sugitharini V, Pavani K, Prema A, Berla Thangam E. TLR-mediated
inflammatory response to neonatal pathogens and co-infection in
neonatal immune cells. Cytokine . 2014;69:211-217.
- Martin R. Pathophysiology, clinical manifestations, and diagnosis of
respiratory distress syndrome in the newborn. In: UpToDate,
Garcia-Prats, JA (Ed), UpToDate, Waltham, MA, USA, 2020.
- Sardesai S, Biniwale M, Wertheimer F, Garingo A, Ramanathan R.
Evolution of surfactant therapy for respiratory distress syndrome:
past, present, and future. Pediatr Res . 2017;81:240-248.
- Pediatric Acute Lung Injury Consensus Conference G. Pediatric acute
respiratory distress syndrome: consensus recommendations from the
Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit
Care Med . 2015;16:428-439.
- Yehya N, Servaes S, Thomas NJ, Nadkarni VM, Srinivasan V.
Corticosteroid exposure in pediatric acute respiratory distress
syndrome. Intensive Care Med . 2015;41:1658-1666.
- Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Early (< 8
days) systemic postnatal corticosteroids for prevention of
bronchopulmonary dysplasia in preterm infants. Cochrane Database
Syst Rev . 2017;10:CD001146.
- Monteverde-Fernandez N, Cristiani F, McArthur J, Gonzalez-Dambrauskas
S. Steroids in pediatric acute respiratory distress syndrome.Ann Transl Med . 2019;7:508.
- Mokra D, Mokry J, Drgova A, Petraskova M, Bulikova J, Calkovska A.
Intratracheally administered corticosteroids improve lung function in
meconium-instilled rabbits. J Physiol Pharmacol . 2007;58 Suppl
5:389-398.
- Lin CH, Jeng MJ, Yang YC, Hsiao YH, Kou YR. Comparison of different
dosing strategies of intratracheally instilled budesonide on meconium
injured piglet lungs. Pediatr Pulmonol . 2017;52:891-899.
- Bassler D, Plavka R, Shinwell ES, Hallman M, Jarreau PH, Carnielli V,
Van den Anker JN, Meisner C, Engel C, Schwab M, Halliday HL, Poets CF,
Group NT. Early inhaled budesonide for the prevention of
bronchopulmonary dysplasia. N Engl J Med . 2015;373:1497-1506.
- Tukova J, Smisek J, Zlatohlavkova B, Plavka R, Markova D. Early
inhaled budesonide in extremely preterm infants decreases long-term
respiratory morbidity. Pediatr Pulmonol . 2020;55:1124-1130.
- Bassler D, Shinwell ES, Hallman M, Jarreau PH, Plavka R, Carnielli V,
Meisner C, Engel C, Koch A, Kreutzer K, van den Anker JN, Schwab M,
Halliday HL, Poets CF; Neonatal European Study of Inhaled Steroids
Trial Group. Long-term effects of inhaled budesonide for
bronchopulmonary dysplasia. N Engl J Med . 2018;378:148-157.
- Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic
corticosteroids for preventing bronchopulmonary dysplasia in
ventilated very low birth weight preterm neonates. Cochrane
Database Syst Rev . 2017;10:CD002058.
- Chakraborty M, Kotecha S. Pulmonary surfactant in newborn infants and
children. Breathe . 2013;9:476-488.
- Boel L, Banerjee S, Chakraborty M. Postnatal steroids in extreme
preterm infants: Intra-tracheal instillation using surfactant as a
vehicle. Paediatr Respir Rev . 2018;25:78-84.
- Chen CM, Chang CH, Chao CH, Wang MH, Yeh TF. Biophysical and chemical
stability of surfactant/budesonide and the pulmonary distribution
following intra-tracheal administration. Drug Deliv .
2019;26:604-611.
- Nimmo AJ, Carstairs JR, Patole SK, Whitehall J, Davidson K, Vink R.
Intratracheal administration of glucocorticoids using surfactant as a
vehicle. Clin Exp Pharmacol Physiol . 2002;29:661-665.
- Ricci F, Catozzi C, Ravanetti F, Murgia X, D’Alo F, Macchidani N,
Sgarbi E, Di Lallo V, Saccani F, Pertile M, Cacchioli A, Catinella S,
Villetti G, Civelli M, Amadei F, Stellari FF, Pioselli B, Salomone F.
In vitro and in vivo characterization of poractant alfa supplemented
with budesonide for safe and effective intratracheal administration.Pediatr Res . 2017;82:1056-1063.
- Huang LT, Yeh TF, Kuo YL, Chen PC, Chen CM. Effect of surfactant and
budesonide on the pulmonary distribution of fluorescent dye in mice.Pediatr Neonatol . 2015;56:19-24.
- Yang CF, Jeng MJ, Soong WJ, Lee YS, Tsao PC, Tang RB. Acute
pathophysiological effects of intratracheal instillation of budesonide
and exogenous surfactant in a neonatal surfactant-depleted piglet
model. Pediatr Neonatol . 2010;51:219-226.
- Lin CH, Jeng MJ, Kuo BI, Kou YR. Effects of surfactant lavage combined
with intratracheal budesonide instillation on meconium-injured piglet
lungs. Pediatr Crit Care Med . 2016;17:e287-95.
- Gie AG, Regin Y, Salaets T, Casiraghi C, Salomone F, Deprest J,
Vanoirbeek J, Toelen J. Intratracheal budesonide/surfactant attenuates
hyperoxia-induced lung injury in preterm rabbits. Am J Physiol
Lung Cell Mol Physiol . 2020;319:L949-L956.
- Hillman NH, Kothe TB, Schmidt AF, Kemp MW, Royse E, Fee E, Salomone F,
Clarke MW, Musk GC, Jobe AH. Surfactant plus budesonide decreases lung
and systemic responses to injurious ventilation in preterm sheep.Am J Physiol Lung Cell Mol Physiol . 2020;318:L41-L48.
- Ikegami M, Berry D, elKady T, Pettenazzo A, Seidner S, Jobe A.
Corticosteroids and surfactant change lung function and protein leaks
in the lungs of ventilated premature rabbits. J Clin Invest .
1987;79:1371-1378.
- Venkataraman R, Kamaluddeen M, Hasan SU, Robertson HL, Lodha A.
Intratracheal administration of budesonide-surfactant in prevention of
bronchopulmonary dysplasia in very low birth weight infants: a
systematic review and meta-analysis. Pediatr Pulmonol .
2017;52:968-975.
- Zhong YY, Li JC, Liu YL, Zhao XB, Male M, Song DK, Bai Y. Early
intratracheal administration of corticosteroid and pulmonary
surfactant for preventing bronchopulmonary dysplasia in preterm
infants with neonatal respiratory distress syndrome: a meta-analysis.Curr Med Sci . 2019;39:493-499.
- McEvoy CT, Ballard PL, Ward RM, Rower JE, Wadhawan R, Hudak ML,
Weitkamp JH, Harris J, Asselin J, Chapin C, Ballard RA.
Dose-escalation trial of budesonide in surfactant for prevention of
bronchopulmonary dysplasia in extremely low gestational age high-risk
newborns (SASSIE). Pediatr Res . 2020;88:629-636.
- Yeh TF, Lin HC, Chang CH, Wu TS, Su BH, Li TC, Pyati S, Tsai CH. Early
intratracheal instillation of budesonide using surfactant as a vehicle
to prevent chronic lung disease in preterm infants: a pilot study.Pediatrics . 2008;121:e1310-1318.
- Deliloglu B, Tuzun F, Cengiz MM, Ozkan H, Duman N. Endotracheal
surfactant combined with budesonide for neonatal ARDS. Front
Pediatr . 2020;8:210.
- Kothe TB, Sadiq FH, Burleyson N, Williams HL, Anderson C, Hillman NH.
Surfactant and budesonide for respiratory distress syndrome: an
observational study. Pediatr Res . 2020;87:940-945.
- Haegens A, Heeringa P, van Suylen RJ, Steele C, Aratani Y, O’Donoghue
RJ, Mutsaers SE, Mossman BT, Wouters EF, Vernooy JH. Myeloperoxidase
deficiency attenuates lipopolysaccharide-induced acute lung
inflammation and subsequent cytokine and chemokine production. J
Immunol. 2009;182:7990-7996.
- Knapp S, Florquin S, Golenbock DT, van der Poll T. Pulmonary
lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung
inflammation in vivo. J Immunol . 2006;176:3189-3195.